{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:20:22Z","timestamp":1792884022576,"version":"4.5.0"},"reference-count":167,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Universidad de Guadalajara, CUCS"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Despite advances in understanding systemic lupus erythematosus (SLE), many challenges remain in unraveling the precise mechanisms behind the disease\u2019s development and progression. Recent evidence has questioned the role of programmed cell death protein 1 (PD-1) in suppressing autoreactive CD4+ T cells during autoimmune responses. Research has investigated the potential impacts of PD-1 on various CD4+ T-cell subpopulations, including T follicular helper (Tfh) cells, circulating Tfh (cTfh) cells, and T peripheral helper (Tph) cells, all of which exhibit substantial PD-1 expression and are closely related to several autoimmune disorders, including SLE. This review highlights the complex role of PD-1 in autoimmunity and emphasizes the imperative for further research to elucidate its functions during autoreactive T-cell responses. Additionally, we address the potential of PD-1 and its ligands as possible therapeutic targets in SLE.<\/jats:p>","DOI":"10.3390\/ijms25147726","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T18:17:32Z","timestamp":1721067452000},"page":"7726","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Exploring the Role of PD-1 in the Autoimmune Response: Insights into Its Implication in Systemic Lupus Erythematosus"],"prefix":"10.3390","volume":"25","author":[{"given":"Nefertari","family":"Sagrero-Fabela","sequence":"first","affiliation":[{"name":"Doctorado en Ciencias Biom\u00e9dicas (DCB), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico"},{"name":"Grupo de Inmunolog\u00eda Molecular, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Ch\u00e1vez-Mireles","sequence":"additional","affiliation":[{"name":"Doctorado en Ciencias Biom\u00e9dicas (DCB), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Celeste","family":"Salazar-Camarena","sequence":"additional","affiliation":[{"name":"Grupo de Inmunolog\u00eda Molecular, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0836-4186","authenticated-orcid":false,"given":"Claudia Azucena","family":"Palafox-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Grupo de Inmunolog\u00eda Molecular, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico"},{"name":"Instituto de Investigaci\u00f3n en Ciencias Biom\u00e9dicas (IICB), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2020.03.007","article-title":"Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases","volume":"181","author":"Fugger","year":"2020","journal-title":"Cell"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41584-020-0480-7","article-title":"New insights into the role of antinuclear antibodies in systemic lupus erythematosus","volume":"16","author":"Pisetsky","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"102283","DOI":"10.1016\/j.coi.2023.102283","article-title":"Immune checkpoint receptors in autoimmunity","volume":"80","author":"Burke","year":"2023","journal-title":"Curr. Opin. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.4049\/jimmunol.0802769","article-title":"Intestinal Tolerance Is Converted to Autoimmune Enteritis upon PD-1 Ligand Blockade","volume":"182","author":"Reynoso","year":"2009","journal-title":"J. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.4049\/jimmunol.181.4.2513","article-title":"Programmed Death Ligand 1 Regulates a Critical Checkpoint for Autoimmune Myocarditis and Pneumonitis in MRL Mice","volume":"181","author":"Lucas","year":"2008","journal-title":"J. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1084\/jem.20022119","article-title":"Critical Role of the Programmed Death-1 (PD-1) Pathway in Regulation of Experimental Autoimmune Encephalomyelitis","volume":"198","author":"Salama","year":"2003","journal-title":"J. Exp. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.20022125","article-title":"The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice","volume":"198","author":"Ansari","year":"2003","journal-title":"J. Exp. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1074-7613(00)80089-8","article-title":"Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor","volume":"11","author":"Nishimura","year":"1999","journal-title":"Immunity"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ana.20514","article-title":"A PD-1 polymorphism is associated with disease progression in multiple sclerosis","volume":"58","author":"Kroner","year":"2005","journal-title":"Ann. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/0961203308093923","article-title":"Association of programmed cell death 1 polymorphisms and systemic lupus erythematosus: A meta-analysis","volume":"18","author":"Lee","year":"2009","journal-title":"Lupus"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"36885","DOI":"10.18632\/oncotarget.16378","article-title":"Meta-analysis of programmed cell death 1 polymorphisms with systemic lupus erythematosus risk","volume":"8","author":"Gao","year":"2017","journal-title":"Oncotarget"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00393-014-1415-y","article-title":"Meta-analysis of genetic polymorphisms in programmed cell death 1. Associations with rheumatoid arthritis, ankylosing spondylitis, and type 1 diabetes susceptibility","volume":"74","author":"Lee","year":"2015","journal-title":"Z. Rheumatol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Huang, Y., Ba, X., Han, L., Wang, H., Lin, W., Chen, Z., and Tu, S. (2023). T peripheral helper cells in autoimmune diseases: What do we know?. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1145573"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/j.1460-2075.1992.tb05481.x","article-title":"Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death","volume":"11","author":"Ishida","year":"1992","journal-title":"EMBO J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/intimm\/10.10.1563","article-title":"Immunological studies on PD-1-deficient mice: Implication of PD-1 as a negative regulator for B cell responses","volume":"10","author":"Nishimura","year":"1998","journal-title":"Int. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/nm955","article-title":"Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice","volume":"9","author":"Okazaki","year":"2003","journal-title":"Nat. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1126\/science.291.5502.319","article-title":"Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice","volume":"291","author":"Nishimura","year":"2001","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Jubel, J.M., Barbati, Z.R., Burger, C., Wirtz, D.C., and Schildberg, F.A. (2020). The Role of PD-1 in Acute and Chronic Infection. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00487"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMra1514296","article-title":"Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway","volume":"375","author":"Boussiotis","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.immuni.2016.05.002","article-title":"Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family","volume":"44","author":"Schildberg","year":"2016","journal-title":"Immunity"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4049\/jimmunol.173.2.945","article-title":"SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation","volume":"173","author":"Chemnitz","year":"2004","journal-title":"J. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"13866","DOI":"10.1073\/pnas.231486598","article-title":"PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine","volume":"98","author":"Okazaki","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J. Exp. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/85330","article-title":"PD-L2 is a second ligand for PD-1 and inhibits T cell activation","volume":"2","author":"Latchman","year":"2001","journal-title":"Nat. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/jcp.27172","article-title":"PD-1\/PD-L1 immune checkpoint: Potential target for cancer therapy","volume":"234","author":"Dermani","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1073\/pnas.1718217115","article-title":"Role of PD-1 during effector CD8 T cell differentiation","volume":"115","author":"Ahn","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1084\/jem.20182395","article-title":"Development of immune checkpoint therapy for cancer","volume":"216","author":"Fritz","year":"2019","journal-title":"J. Exp. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-016-0160-z","article-title":"T cell exhaustion: From pathophysiological basics to tumor immunotherapy","volume":"15","author":"Catakovic","year":"2017","journal-title":"Cell Commun. Signal."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.it.2015.02.008","article-title":"Overcoming T cell exhaustion in infection and cancer","volume":"36","author":"Pauken","year":"2015","journal-title":"Trends Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Wakabayashi, G., Lee, Y.C., Luh, F., Kuo, C.N., Chang, W.C., and Yen, Y. (2019). Development and clinical applications of cancer immunotherapy against PD-1 signaling pathway. J. Biomed. Sci., 26.","DOI":"10.1186\/s12929-019-0588-8"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1749-6632.2010.05919.x","article-title":"The role of the PD-1 pathway in autoimmunity and peripheral tolerance","volume":"1217","author":"Fife","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1084\/jem.191.5.891","article-title":"Facilitation of \u03b2 Selection and Modification of Positive Selection in the Thymus of Pd-1\u2013Deficient Mice","volume":"191","author":"Nishimura","year":"2000","journal-title":"J. Exp. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"7372","DOI":"10.4049\/jimmunol.175.11.7372","article-title":"Programmed Death-1 (PD-1):PD-Ligand 1 Interactions Inhibit TCR-Mediated Positive Selection of Thymocytes","volume":"175","author":"Keir","year":"2005","journal-title":"J. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.4049\/jimmunol.171.9.4574","article-title":"Absence of Programmed Death Receptor 1 Alters Thymic Development and Enhances Generation of CD4\/CD8 Double-Negative TCR-Transgenic T Cells","volume":"171","author":"Blank","year":"2003","journal-title":"J. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e2120149119","DOI":"10.1073\/pnas.2120149119","article-title":"PD-1 cooperates with AIRE-mediated tolerance to prevent lethal autoimmune disease","volume":"119","author":"Policheni","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ni1165","article-title":"Resting dendritic cells induce peripheral CD8+ T cell tolerance in vivo through PD-1 and CTLA-4","volume":"6","author":"Probst","year":"2005","journal-title":"Nat. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"102976","DOI":"10.1016\/j.jaut.2022.102976","article-title":"T follicular helper cells in autoimmune diseases","volume":"134","author":"Wei","year":"2023","journal-title":"J. Autoimmun."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e2250075","DOI":"10.1002\/eji.202250075","article-title":"Interleukin-21 in autoimmune and inflammatory skin diseases","volume":"53","author":"Bodner","year":"2023","journal-title":"Eur. J. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.immuni.2008.06.001","article-title":"A Fundamental Role for Interleukin-21 in the Generation of T Follicular Helper Cells","volume":"29","author":"Vogelzang","year":"2008","journal-title":"Immunity"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.immuni.2008.05.009","article-title":"Generation of T Follicular Helper Cells Is Mediated by Interleukin-21 but Independent of T Helper 1, 2, or 17 Cell Lineages","volume":"29","author":"Nurieva","year":"2008","journal-title":"Immunity"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1007\/s10067-018-4124-0","article-title":"Aberrant T cell subsets and cytokines expression profile in systemic lupus erythematosus","volume":"37","author":"Zhou","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/14397595.2018.1469581","article-title":"Associations of circulating CXCR3\u2013PD-1+CD4+T cells with disease activity of systemic lupus erythematosus","volume":"29","author":"Han","year":"2019","journal-title":"Mod. Rheumatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1177\/0961203314567750","article-title":"Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production","volume":"24","author":"Zhang","year":"2015","journal-title":"Lupus"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/art.39020","article-title":"Circulating follicular helper-like T cells in systemic lupus erythematosus: Association with disease activity","volume":"67","author":"Choi","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.3899\/jrheum.131025","article-title":"Increased Interleukin 21 and Follicular Helper T-like Cells and Reduced Interleukin 10+ B cells in Patients with New-onset Systemic Lupus Erythematosus","volume":"41","author":"Wang","year":"2014","journal-title":"J. Rheumatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.12659\/MSM.914868","article-title":"CD4+CXCR5+PD-1+ T Follicular Helper Cells Play a Pivotal Role in the Development of Rheumatoid Arthritis","volume":"25","author":"Cao","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"R255","DOI":"10.1186\/ar4100","article-title":"A regulatory effect of IL-21 on T follicular helper-like cell and B cell in rheumatoid arthritis","volume":"14","author":"Liu","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10238-018-0530-5","article-title":"Imbalance of circulating Tfr\/Tfh ratio in patients with rheumatoid arthritis","volume":"19","author":"Wang","year":"2019","journal-title":"Clin. Exp. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/art.40424","article-title":"The Ratio of Blood T Follicular Regulatory Cells to T Follicular Helper Cells Marks Ectopic Lymphoid Structure Formation While Activated Follicular Helper T Cells Indicate Disease Activity in Primary Sj\u00f6gren\u2019s Syndrome","volume":"70","author":"Fonseca","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.4110\/in.2019.19.e26","article-title":"Circulating CCR7loPD-1hi Follicular Helper T Cells Indicate Disease Activity and Glandular Inflammation in Patients with Primary Sj\u00f6gren\u2019s Syndrome","volume":"19","author":"Kim","year":"2019","journal-title":"Immune Netw."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1136\/annrheumdis-2020-217646","article-title":"Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sj\u00f6gren\u2019s syndrome with ectopic germinal centres and MALT lymphoma","volume":"79","author":"Pontarini","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/cei.12703","article-title":"A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sj\u00f6gren\u2019s syndrome and systemic lupus erythematosus","volume":"183","author":"Papp","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Szab\u00f3, K., J\u00e1mbor, I., Sz\u00e1nt\u00f3, A., Horv\u00e1th, I.F., Tarr, T., Nakken, B., Szodoray, P., and Papp, G. (2021). The Imbalance of Circulating Follicular T Helper Cell Subsets in Primary Sj\u00f6gren\u2019s Syndrome Associates With Serological Alterations and Abnormal B-Cell Distribution. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.639975"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/cei.13596","article-title":"Altered distributions in circulating follicular helper and follicular regulatory T cells accountable for imbalanced cytokine production in multiple sclerosis","volume":"205","author":"Haque","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Guo, J., Zhao, C., Wu, F., Tao, L., Zhang, C., Zhao, D., Yang, S., Jiang, D., Wang, J., and Sun, Y. (2018). T follicular helper-like cells are involved in the pathogenesis of experimental autoimmune encephalomyelitis. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00944"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1093\/rheumatology\/kez228","article-title":"PD-1+CXCR5\u2212CD4+T cells are correlated with the severity of systemic lupus erythematosus","volume":"58","author":"Lin","year":"2019","journal-title":"Rheumatology"},{"key":"ref_59","first-page":"1861","article-title":"Expanded circulating peripheral helper T cells in systemic lupus erythematosus: Association with disease activity and B cell differentiation","volume":"58","author":"Makiyama","year":"2019","journal-title":"Rheumatology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1177\/09612033231189804","article-title":"BAFFR expression in circulating T follicular helper (CD4+CXCR5+PD-1+) and T peripheral helper (CD4+CXCR5\u2212PD-1+) cells in systemic lupus erythematosus","volume":"32","author":"Cruz","year":"2023","journal-title":"Lupus"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3892\/etm.2022.11579","article-title":"Increased TIGIT+PD-1+CXCR5-CD4+T cells are associated with disease activity in rheumatoid arthritis","volume":"24","author":"Luo","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/1756-185X.14170","article-title":"Circulating CD4+FoxP3\u2013CXCR5\u2013CXCR3+PD-1hi cells are elevated in active rheumatoid arthritis and reflect the severity of the disease","volume":"24","author":"Zhao","year":"2021","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis","volume":"542","author":"Rao","year":"2017","journal-title":"Nature"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.4049\/jimmunol.2000783","article-title":"Autoreactivity of Peripheral Helper T Cells in the Joints of Rheumatoid Arthritis","volume":"206","author":"Sakuragi","year":"2021","journal-title":"J. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Chen, W., Yang, F., and Lin, J. (2022). Tph Cells Expanded in Primary Sj\u00f6gren\u2019s Syndrome. Front. Med., 9.","DOI":"10.3389\/fmed.2022.900349"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e001442","DOI":"10.1136\/rmdopen-2020-001442","article-title":"Association between T follicular helper cells and T peripheral helper cells with B-cell biomarkers and disease activity in primary Sj\u00f6gren syndrome","volume":"7","author":"Pascaud","year":"2021","journal-title":"RMD Open"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nri.2015.1","article-title":"Regulatory T cell memory","volume":"16","author":"Rosenblum","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41590-018-0120-4","article-title":"Regulatory T cells in autoimmune disease","volume":"19","author":"Hafler","year":"2018","journal-title":"Nat. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1084\/jem.20090847","article-title":"PD-L1 regulates the development, maintenance, and function of induced regulatory T cells","volume":"206","author":"Francisco","year":"2009","journal-title":"J. Exp. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"111ra120","DOI":"10.1126\/scitranslmed.3003130","article-title":"The PDL1-PD1 axis converts human T H1 cells into regulatory T cells","volume":"3","author":"Amarnath","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"155119","DOI":"10.1016\/j.cyto.2020.155119","article-title":"Low expressions of PD-L1 and CTLA-4 by induced CD4+CD25+ Foxp3+ Tregs in patients with SLE and their correlation with the disease activity","volume":"133","author":"Zhao","year":"2020","journal-title":"Cytokine"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Ferreira, R.C., Castro Dopico, X., Oliveira, J.J., Rainbow, D.B., Yang, J.H., Trzupek, D., Todd, S.A., McNeill, M., Steri, M., and Orr\u00f9, V. (2019). Chronic Immune Activation in Systemic Lupus Erythematosus and the Autoimmune PTPN22 Trp620 Risk Allele Drive the Expansion of FOXP3+ Regulatory T Cells and PD-1 Expression. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02606"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.4049\/jimmunol.181.7.4832","article-title":"NFATc1 regulates PD-1 expression upon T cell activation","volume":"181","author":"Oestreich","year":"2008","journal-title":"J. Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.4049\/jimmunol.1302750","article-title":"STAT3, STAT4, NFATc1, and CTCF regulate PD-1 through multiple novel regulatory regions in murine T cells","volume":"192","author":"Austin","year":"2014","journal-title":"J. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/intimm\/dxab059","article-title":"STAT5 interferes with PD-1 transcriptional activation and affects CD8+ T-cell sensitivity to PD-1-dependent immunoregulation","volume":"33","author":"Wang","year":"2021","journal-title":"Int. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.4049\/jimmunol.1003208","article-title":"IFN-\u03b1 directly promotes programmed cell death-1 transcription and limits the duration of T cell-mediated immunity","volume":"186","author":"Terawaki","year":"2011","journal-title":"J. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"15419","DOI":"10.1073\/pnas.1206370109","article-title":"Activator protein 1 suppresses antitumor T-cell function via the induction of programmed death 1","volume":"109","author":"Xiao","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.immuni.2014.10.013","article-title":"The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8(+) T cells during chronic infection","volume":"41","author":"Staron","year":"2014","journal-title":"Immunity"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1007\/s00018-020-03737-y","article-title":"Transcriptional and epigenetic regulation of PD-1 expression","volume":"78","author":"Chi","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.celrep.2017.07.027","article-title":"Blockage of Core Fucosylation Reduces Cell-Surface Expression of PD-1 and Promotes Anti-tumor Immune Responses of T Cells","volume":"20","author":"Okada","year":"2017","journal-title":"Cell Rep."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"17765","DOI":"10.1073\/pnas.0708767104","article-title":"Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability","volume":"104","author":"Chen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/icb.2012.53","article-title":"Notch signaling regulates PD-1 expression during CD8+ T-cell activation","volume":"91","author":"Mathieu","year":"2013","journal-title":"Immunol. Cell Biol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1084\/jem.20130208","article-title":"Blimp-1 represses CD8 T cell expression of PD-1 using a feed-forward transcriptional circuit during acute viral infection","volume":"211","author":"Lu","year":"2014","journal-title":"J. Exp. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ni.2046","article-title":"Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection","volume":"12","author":"Kao","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.immuni.2009.06.019","article-title":"A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection","volume":"31","author":"Shin","year":"2009","journal-title":"Immunity"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2119\/molmed.2010.00175","article-title":"Expression of a broad array of negative costimulatory molecules and Blimp-1 in T cells following priming by HIV-1 pulsed dendritic cells","volume":"17","author":"Shankar","year":"2011","journal-title":"Mol. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2119\/molmed.2012.00103","article-title":"p38 mitogen-activated protein kinase\/signal transducer and activator of transcription-3 pathway signaling regulates expression of inhibitory molecules in T Cells activated by HIV-1-exposed dendritic cells","volume":"18","author":"Che","year":"2012","journal-title":"Mol. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1074\/jbc.AC119.011747","article-title":"The structural features that distinguish PD-L2 from PD-L1 emerged in placental mammals","volume":"295","author":"Philips","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Bardhan, K., Anagnostou, T., and Boussiotis, V.A. (2016). The PD1:PD-L1\/2 Pathway from Discovery to Clinical Implementation. Front. Immunol., 7.","DOI":"10.3389\/fimmu.2016.00550"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0165-2478(02)00142-6","article-title":"Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues","volume":"84","author":"Ishida","year":"2002","journal-title":"Immunol. Lett."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"102702","DOI":"10.1016\/j.jaut.2021.102702","article-title":"Cellular and molecular regulation of the programmed death-1\/programmed death ligand system and its role in multiple sclerosis and other autoimmune diseases","volume":"123","author":"Vilchez","year":"2021","journal-title":"J. Autoimmun."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","article-title":"Regulation and Function of the PD-L1 Checkpoint","volume":"48","author":"Sun","year":"2018","journal-title":"Immunity"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13045-020-01027-5","article-title":"Regulation of PD-L1 expression in the tumor microenvironment","volume":"14","author":"Yi","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/cmi.2017.17","article-title":"B7-DC (PD-L2) costimulation of CD4+ T-helper 1 response via RGMb","volume":"15","author":"Nie","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"103707","DOI":"10.1016\/j.critrevonc.2022.103707","article-title":"Tissue and circulating PD-L2: Moving from health and immune-mediated diseases to head and neck oncology","volume":"175","author":"Muraro","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"eaav7431","DOI":"10.1126\/scitranslmed.aav7431","article-title":"Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy","volume":"12","author":"Mayoux","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1084\/jem.185.3.393","article-title":"CD80 (B7-1) Binds Both CD28 and CTLA-4 with a Low Affinity and Very Fast Kinetics","volume":"185","author":"Bodian","year":"1997","journal-title":"J. Exp. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1016\/j.molimm.2008.05.014","article-title":"Interaction of human PD-L1 and B7-1","volume":"45","author":"Butte","year":"2008","journal-title":"Mol. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1126\/science.aav7062","article-title":"Restriction of PD-1 function by cis-PD-L1\/CD80 interactions is required for optimal T cell responses","volume":"364","author":"Sugiura","year":"2019","journal-title":"Science"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.immuni.2019.11.003","article-title":"Article PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways","volume":"51","author":"Zhao","year":"2019","journal-title":"Immunity"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1038\/s41467-023-40982-8","article-title":"PD-L1 positive astrocytes attenuate inflammatory functions of PD-1 positive microglia in models of autoimmune neuroinflammation","volume":"14","author":"Linnerbauer","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1002\/art.27500","article-title":"The programmed death 1\/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis","volume":"62","author":"Raptopoulou","year":"2010","journal-title":"Arthritis Rheum."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41590-021-01125-7","article-title":"PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity","volume":"23","author":"Sugiura","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cellimm.2005.07.007","article-title":"Alternative splice variants of the human PD-1 gene","volume":"235","author":"Nielsen","year":"2005","journal-title":"Cell. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s40425-018-0449-0","article-title":"Soluble immune checkpoints in cancer: Production, function and biological significance","volume":"6","author":"Gu","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Kir\u00e1ly, Z., Nagy, E., Bokor, L., Kov\u00e1cs, A., Marschalk\u00f3, M., and Hidv\u00e9gi, B. (2023). The Possible Clinical Significance of a Decreased Serum Level of Soluble PD-L1 in Discoid Lupus Erythematosus, but Not in Subacute Cutaneous Lupus Erythematosus\u2014A Pilot Study. J. Clin. Med., 12.","DOI":"10.3390\/jcm12175648"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1177\/0961203320916517","article-title":"Serum levels of soluble programmed cell death protein 1 and soluble programmed cell death protein ligand 2 are increased in systemic lupus erythematosus and associated with the disease activity","volume":"29","author":"Hirahara","year":"2020","journal-title":"Lupus"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e12884","DOI":"10.1111\/sji.12884","article-title":"Serum levels of soluble programmed death-1 (sPD-1) and soluble programmed death ligand 1(sPD-L1) in systemic lupus erythematosus: Association with activity and severity","volume":"92","author":"Du","year":"2020","journal-title":"Scand. J. Immunol."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Xu, L., Jiang, L., Nie, L., Zhang, S., Liu, L., Du, Y., and Xue, J. (2021). Soluble programmed death molecule 1 (sPD-1) as a predictor of interstitial lung disease in rheumatoid arthritis. BMC Immunol., 22.","DOI":"10.1186\/s12865-021-00460-6"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/03009742.2013.823517","article-title":"Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis","volume":"43","author":"Greisen","year":"2014","journal-title":"Scand. J. Rheumatol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s13075-015-0859-z","article-title":"Soluble PD-1 aggravates progression of collagen-induced arthritis through Th1 and Th17 pathways","volume":"17","author":"Liu","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/1756-185X.13391","article-title":"Influence of total glucosides of paeony on PD-1\/PD-L1 expression in primary Sj\u00f6gren\u2019s syndrome","volume":"22","author":"Chen","year":"2019","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/cei\/uxab003","article-title":"CMTM6: Increased circulating level and up-regulated expression in labial salivary glands in patients with primary Sjogren\u2019s syndrome","volume":"207","author":"Qian","year":"2022","journal-title":"Clin. Exp. Immunol."},{"key":"ref_114","first-page":"116","article-title":"Serum soluble programmed cell death protein 1 could predict the current activity and severity of antineutrophil cytoplasmic antibody-associated vasculitis: A monocentric prospective study","volume":"37","author":"Yoon","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Bailly, C., Thuru, X., and Quesnel, B. (2021). Soluble programmed death ligand-1 (Spd-l1): A pool of circulating proteins implicated in health and diseases. Cancers, 13.","DOI":"10.3390\/cancers13123034"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1745-7254.2005.00086.x","article-title":"Identification of a novel splice variant of human PD-L1 mRNA encoding an isoform-lacking Igv-like domain","volume":"26","author":"He","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/abbs\/36.4.284","article-title":"Cloning and Identification of Two Novel Splice Variants of Human PD-L2","volume":"36","author":"He","year":"2004","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Niu, M., Liu, Y., Yi, M., Jiao, D., and Wu, K. (2022). Biological Characteristics and Clinical Significance of Soluble PD-1\/PD-L1 and Exosomal PD-L1 in Cancer. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.827921"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/art.24227","article-title":"Genetic, immunologic, and immunohistochemical analysis of the programmed death 1\/programmed death ligand 1 pathway in human systemic lupus erythematosus","volume":"60","author":"Bertsias","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Liu, M.F., Weng, C.T., and Weng, M.Y. (2009). Variable increased expression of program death-1 and program death-1 ligands on peripheral mononuclear cells is not impaired in patients with systemic lupus erythematosus. J. Biomed. Biotechnol., 2009.","DOI":"10.1155\/2009\/406136"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13075-016-0942-0","article-title":"PD-L1-expressing neutrophils as a novel indicator to assess disease activity and severity of systemic lupus erythematosus","volume":"18","author":"Luo","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clim.2018.11.015","article-title":"The role and clinical significance of programmed cell death- ligand 1 expressed on CD19+B-cells and subsets in systemic lupus erythematosus","volume":"198","author":"Jia","year":"2019","journal-title":"Clin. Immunol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10067-020-05220-2","article-title":"Patients with systemic lupus erythematosus show increased proportions of CD19+CD20\u2212 B cells and secretion of related autoantibodies","volume":"40","author":"Zhu","year":"2021","journal-title":"Clin. Rheumatol."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Rincon-Arevalo, H., Wiedemann, A., Stefanski, A.-L., Lettau, M., Szelinski, F., Fuchs, S., Frei, A.P., Steinberg, M., Kam-Thong, T., and Hatje, K. (2021). Deep Phenotyping of CD11c+ B Cells in Systemic Autoimmunity and Controls. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.635615"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13075-017-1258-4","article-title":"Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus erythematosus patients","volume":"19","author":"Shi","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.imlet.2020.09.001","article-title":"Abnormal membrane-bound and soluble programmed death ligand 2 (PD-L2) expression in systemic lupus erythematosus is associated with disease activity","volume":"227","author":"Tong","year":"2020","journal-title":"Immunol. Lett."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00251-023-01307-7","article-title":"Dysregulated PD-L2 is correlated with disease activity and inflammation in rheumatoid arthritis","volume":"75","author":"Xiong","year":"2023","journal-title":"Immunogenetics"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Guo, Y., Walsh, A.M., Canavan, M., Wechalekar, M.D., Cole, S., Yin, X., Scott, B., Loza, M., Orr, C., and McGarry, T. (2018). Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0192704"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10238-018-0515-4","article-title":"Clinicopathological value of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) expression in synovium of patients with rheumatoid arthritis","volume":"18","author":"Matsuda","year":"2018","journal-title":"Clin. Exp. Med."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1186\/s13075-014-0497-x","article-title":"Synovial T cell hyporesponsiveness to myeloid dendritic cells is reversed by preventing PD-1\/PD-L1 interactions","volume":"16","author":"Moret","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.4049\/jimmunol.177.12.8844","article-title":"Aberrant Regulation of Synovial T Cell Activation by Soluble Costimulatory Molecules in Rheumatoid Arthritis","volume":"177","author":"Wan","year":"2006","journal-title":"J. Immunol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/cei.12949","article-title":"Inflammatory cytokines compromise programmed cell death-1 (PD-1)-mediated T cell suppression in inflammatory arthritis through up-regulation of soluble PD-1","volume":"188","author":"Bommarito","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"ref_133","first-page":"2156","article-title":"Enhanced expression of programmed death-1 (PD-1)\/PD-L1 in salivary glands of patients with Sj\u00f6gren\u2019s syndrome","volume":"32","author":"Kobayashi","year":"2005","journal-title":"J. Rheumatol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.55563\/clinexprheumatol\/fp741f","article-title":"Serum CXCL13, BAFF, IL-21 and IL-22 levels are related to disease activity and lymphocyte profile in primary Sj\u00f6gren\u2019s syndrome","volume":"39","author":"Palacio","year":"2021","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13075-016-1006-1","article-title":"Identification of definitive serum biomarkers associated with disease activity in primary Sj\u00f6gren\u2019s syndrome","volume":"18","author":"Nishikawa","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.4049\/jimmunol.0901038","article-title":"Costimulatory Pathways in Multiple Sclerosis: Distinctive Expression of PD-1 and PD-L1 in Patients with Different Patterns of Disease","volume":"183","author":"Trabattoni","year":"2009","journal-title":"J. Immunol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression","volume":"19","author":"Shin","year":"2017","journal-title":"Cell Rep."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.neo.2017.02.006","article-title":"Identifying Regulatory Posttranslational Modifications of PD-L1: A Focus on Monoubiquitinaton","volume":"19","author":"Horita","year":"2017","journal-title":"Neoplasia"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"12632","DOI":"10.1038\/ncomms12632","article-title":"Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity","volume":"7","author":"Li","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41551-019-0375-6","article-title":"Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours","volume":"3","author":"Yao","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nrm2084","article-title":"Palmitoylation: Policing protein stability and traffic","volume":"8","author":"Linder","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Yu, X., Li, W., Young, K.H., and Li, Y. (2021). Posttranslational Modifications in PD-L1 Turnover and Function: From Cradle to Grave. Biomedicines, 9.","DOI":"10.3390\/biomedicines9111702"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature23643","article-title":"CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity","volume":"549","author":"Burr","year":"2017","journal-title":"Nature"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature23669","article-title":"Identification of CMTM6 and CMTM4 as PD-L1 protein regulators","volume":"549","author":"Mezzadra","year":"2017","journal-title":"Nature"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/gepi.21739","article-title":"Encore: Genetic Association Interaction Network Centrality Pipeline and Application to SLE Exome Data","volume":"37","author":"Davis","year":"2013","journal-title":"Genet. Epidemiol."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Zeisbrich, M., Chevalier, N., Sehnert, B., Rizzi, M., Venhoff, N., Thiel, J., and Voll, R.E. (2021). CMTM6-Deficient Monocytes in ANCA-Associated Vasculitis Fail to Present the Immune Checkpoint PD-L1. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.673912"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1126\/science.aaf1292","article-title":"T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition","volume":"355","author":"Hui","year":"2017","journal-title":"Science"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cellimm.2016.09.009","article-title":"PD-1\/PD-L and autoimmunity: A growing relationship","volume":"310","author":"Zamani","year":"2016","journal-title":"Cell. Immunol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"18036","DOI":"10.1074\/jbc.RA120.014745","article-title":"Quantitative phosphoproteomic analysis reveals involvement of PD-1 in multiple T cell functions","volume":"295","author":"Tocheva","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/imm.13388","article-title":"PD-1-induced proliferating T cells exhibit a distinct transcriptional signature","volume":"164","author":"Strazza","year":"2021","journal-title":"Immunology"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"103020","DOI":"10.1016\/j.isci.2021.103020","article-title":"PD-1-stimulated T cell subsets are transcriptionally and functionally distinct","volume":"24","author":"Lerrer","year":"2021","journal-title":"iScience"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.4049\/jimmunol.179.8.5099","article-title":"Role of CXCR5 and CCR7 in Follicular Th Cell Positioning and Appearance of a Programmed Cell Death Gene-1High Germinal Center-Associated Subpopulation","volume":"179","author":"Haynes","year":"2007","journal-title":"J. Immunol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ni.1877","article-title":"PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells","volume":"11","author":"Szumilas","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.4049\/jimmunol.1201678","article-title":"IL-21 and CD40L Synergistically Promote Plasma Cell Differentiation through Upregulation of Blimp-1 in Human B Cells","volume":"190","author":"Ding","year":"2013","journal-title":"J. Immunol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1126\/science.1217718","article-title":"The inhibitory receptor PD-1 regulates IgA selection and bacterial composition in the gut","volume":"336","author":"Kawamoto","year":"2012","journal-title":"Science"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.immuni.2018.06.012","article-title":"PD-1 Controls Follicular T Helper Cell Positioning and Function Article PD-1 Controls Follicular T Helper Cell Positioning and Function","volume":"49","author":"Shi","year":"2018","journal-title":"Immunity"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.immuni.2011.03.023","article-title":"ICOS Receptor Instructs T Follicular Helper Cell versus Effector Cell Differentiation via Induction of the Transcriptional Repressor Bcl6","volume":"34","author":"Choi","year":"2011","journal-title":"Immunity"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"6738","DOI":"10.4049\/jimmunol.181.10.6738","article-title":"The Common \u03b3-Chain Cytokines IL-2, IL-7, IL-15, and IL-21 Induce the Expression of Programmed Death-1 and Its Ligands","volume":"181","author":"Kinter","year":"2008","journal-title":"J. Immunol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"735","DOI":"10.4161\/onci.20823","article-title":"PD-1 and BTLA and CD8+ T-cell \u201cexhaustion\u201d in cancer: \u201cExercising\u201d an alternative viewpoint","volume":"1","author":"Haymaker","year":"2012","journal-title":"Oncoimmunology"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"R157","DOI":"10.1186\/ar3474","article-title":"Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus","volume":"13","author":"Dolff","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Paluch, C., Santos, A.M., Anzilotti, C., Cornall, R.J., and Davis, S.J. (2018). Immune checkpoints as therapeutic targets in autoimmunity. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02306"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000480641","article-title":"The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis","volume":"46","author":"Liao","year":"2017","journal-title":"Am. J. Nephrol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"e2102164118","DOI":"10.1073\/pnas.2102164118","article-title":"Computational design of a synthetic PD-1 agonist","volume":"118","author":"Bryan","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"e152468","DOI":"10.1172\/jci.insight.152468","article-title":"Cell-targeted PD-1 agonists that mimic PD-L1 are potent T cell inhibitors","volume":"6","author":"Curnock","year":"2021","journal-title":"JCI Insight"},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Guo, Q., Chen, C., Wu, Z., Zhang, W., Wang, L., Yu, J., Li, L., Zhang, J., and Duan, Y. (2022). Engineered PD-1\/TIGIT dual-activating cell-membrane nanoparticles with dexamethasone act synergistically to shape the effector T cell\/Treg balance and alleviate systemic lupus erythematosus. Biomaterials, 285.","DOI":"10.1016\/j.biomaterials.2022.121517"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/08820139.2023.2250818","article-title":"Regulatory Rheumatoid Factor is Specific to PD-1 and Uses PD-1 Pathway to Control CD4 T Lymphocytes","volume":"52","author":"Khramova","year":"2023","journal-title":"Immunol. Investig."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Wang, B., Chen, C., Liu, X., Zhou, S., Xu, T., and Wu, M. (2023). The effect of combining PD-1 agonist and low-dose Interleukin-2 on treating systemic lupus erythematosus. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1111005"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/14\/7726\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:16:53Z","timestamp":1760109413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/14\/7726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,15]]},"references-count":167,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["ijms25147726"],"URL":"https:\/\/doi.org\/10.3390\/ijms25147726","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,15]]}}}